17-63498093-ACT-ACTCT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_000789.4(ACE):c.*730_*731dupCT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.52 ( 20935 hom., cov: 0)
Exomes 𝑓: 0.41 ( 237 hom. )
Consequence
ACE
NM_000789.4 3_prime_UTR
NM_000789.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.813
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 17-63498093-A-ACT is Benign according to our data. Variant chr17-63498093-A-ACT is described in ClinVar as [Benign]. Clinvar id is 324435.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.6 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACE | ENST00000290866.10 | c.*730_*731dupCT | 3_prime_UTR_variant | 25/25 | 1 | NM_000789.4 | ENSP00000290866.4 | |||
ENSG00000264813 | ENST00000577647.2 | n.1969+1111_1969+1112dupCT | intron_variant | 2 | ENSP00000464149.1 | |||||
ACE | ENST00000428043.5 | c.*1073_*1074dupCT | 3_prime_UTR_variant | 24/24 | 2 | ENSP00000397593.2 |
Frequencies
GnomAD3 genomes AF: 0.521 AC: 79162AN: 151808Hom.: 20880 Cov.: 0
GnomAD3 genomes
AF:
AC:
79162
AN:
151808
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.407 AC: 951AN: 2334Hom.: 237 Cov.: 0 AF XY: 0.412 AC XY: 480AN XY: 1164
GnomAD4 exome
AF:
AC:
951
AN:
2334
Hom.:
Cov.:
0
AF XY:
AC XY:
480
AN XY:
1164
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.522 AC: 79281AN: 151926Hom.: 20935 Cov.: 0 AF XY: 0.523 AC XY: 38842AN XY: 74242
GnomAD4 genome
AF:
AC:
79281
AN:
151926
Hom.:
Cov.:
0
AF XY:
AC XY:
38842
AN XY:
74242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
2304
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Renal tubular dysgenesis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at